HIV/AIDS Prevention and Care Project: Project Design Document. AusAID (2000)

HIV/AIDS Prevention and Care Project: Project Design Document. AusAID (2000) In 1999 the Government of the Peoples Republic of China (GoPRC) in Xinjiang-Uygur Autonomous Region (Xinjiang) submitted a project proposal, Project Proposal on HIV/AIDS Prevention and Control in Xinjiang Uygur Autonomous Region, to the Australian Government (GoA) through the GoPRC Ministry of Foreign Trade and Economic Cooperation (MoFTEC) for funding through the Australian Agency for International Development (AusAID). The proposal was in response to Xinjiang having the second highest number of people with HIV/AIDS in PRC and the highest rate of increase.

Download this publication

HIV-Related Opportunistic Diseases - UNAIDS Technical Update. UNAIDS (1998)

HIV-Related Opportunistic Diseases - UNAIDS Technical Update. UNAIDS (1998) Opportunistic diseases in a person with HIV are the products of two things: the person’s lack of immune defences caused by the virus, and the presence of microbes and other pathogens in our everyday environment.

Download this publication

HIV Self-testing: What You Need to Know. UNAIDS. (2018)


People can test wherever and whenever they want. HIV self-testing empowers people to find out their HIV status wherever and whenever they want. Since it is easy, quick and private, people may be encouraged to take a test earlier than they would if they had to visit a health facility, potentially bringing an earlier diagnosis. Any HIV-positive result must, however, be followed up with a second test by a health-care provider to confirm the result and get linked to appropriate prevention, treatment and care.

Keywords: HIV, self-testing, privacy


Download Infographics

Update of Recommendations on First- and Second-line Antiretroviral Regimens. WHO. (2019)


These guidelines provide further reassurance of DTG as the preferred antiretroviral (ARV) drug in first- and second-line regimens due to the declining estimate of neural tube defect risk and observed efficacy. This reassurance comes at a time when pretreatment resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTI) is increasing in low- and middle-income countries, creating demand for access to alternative non-NNRTI ARV drugs.


Keywords: HIV, ARV, treatment, drugs, access


Download Publication

Global Forecasts of Antiretroviral Demand for 2014–2018, Projection Modelling of New Antitretroviral Formulations for 2015–2024 and Update on Hepatitis B and C. WHO. (2015)


The World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) Secretariat organize an annual meeting with pharmaceutical companies and stakeholders to discuss antiretroviral (ARV) drug demand forecasts for adults and children.


The March 2015 meeting went beyond the usual three- year forecast by including a model of new ARVs that will be needed up to 2024. For the first time this year, the meeting also included a discussion on hepatitis B and C medicines. 

Keywords: HIV infections, therapy, drug, ARV, children

Download Publication


Data Dashboard
Highlighted publications
Calendar of events
(1 Mar - 1 Mar)
(8 Mar - 8 Mar)